Eikon Therapeutics, Inc. Common Stock (EIKN) — Defensive Interval Ratio
Eikon Therapeutics, Inc. Common Stock (EIKN) has a Defensive Interval Ratio of 2565 days as of June 2026. Defensive assets of $388.56 Million (cash $-, short-term investments $388.56 Million, receivables $-) cover 2565 days of daily cash needs of $151.50K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Eikon Therapeutics, Inc. Common Stock Defensive Interval Ratio (2023–2025)
This chart shows how Eikon Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 2565 days, meaning defensive assets of $388.56 Million can fund 2565 days of operations without new revenue. For the complete balance sheet picture, see EIKN total asset value.
Annual Defensive Interval Ratio for Eikon Therapeutics, Inc. Common Stock (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for Eikon Therapeutics, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital to net assets of Eikon Therapeutics, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1533 days | $231.07 Million | $150.70K/day | $- | $231.07 Million | ▲ +945 days |
| 2024 | 588 days | $90.93 Million | $154.65K/day | $- | $90.93 Million | ▼ -3100 days |
| 2023 | 3687 days | $317.63 Million | $86.14K/day | $- | $317.63 Million | — |